Intracellular delivery of docetaxel using freeze-dried polysaccharide nanocapsules

Journal of Microencapsulation

Volumn 30, Issue 2, 2013, Pages 181-188

  Lozano, M V ^a,b   Esteban, H ^a   Brea, J ^a   Loza, M I ^a   Torres, D ^a   Alonso, M J ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Universidade de Santiago de Compostela and Instituto de Investigación Sanitaria de Santiago de Compostela   (Spain)

Author keywords

Cancer therapy; Chitosan; Docetaxel; Nanocapsules; Nanocarrier; Polysaccharide

Indexed keywords

DOCETAXEL; NANOCAPSULE; POLOXAMER; POLYSACCHARIDE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL VIABILITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; FREEZE DRYING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PARTICLE SIZE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHITOSAN; DRUG DELIVERY SYSTEMS; FREEZE DRYING; HUMANS; NANOCAPSULES; NEOPLASMS; POLOXAMER; TAXOIDS;

EID: 84873031240     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2012.714411     Document Type: Article

References (35)

1. Abdelwahed W, Degobert G, Fessi H. Freeze-drying of nanocapsules: Impact of annealing on the drying process. Int J Pharm, 2006a;324:74-82.
2. Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm, 2006b;63:87-94.
3. Abdelwahed W, Degobert G, Fessi H. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): Formulation and process optimization. Int J Pharm, 2006c; 309:178-88.
4. Alexis F, Pridgen EM, Langer R, Farokhzad OC. 2010. Nanoparticle technologies for cancer therapy. In: Schafer-Korting M, ed. Handbook of experimental pharmacology. Heidelberg: Springer-Verlag Berlin, pp. 55-86.
5. Bae KH, Lee Y, Park TG. Oil-encapsulating PEO-PPO-PEO/PEG shell crosslinked nanocapsules for target-specific delivery of paclitaxel. Biomacromolecules, 2007;8:650-6.
6. Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev, 2008;60:1615-26.
7. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions. Colloid Polym Sci, 1997a;275:46-53.
8. Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm, 1997b;153:41-50.
9. Choi MJ, Briançon S, Andrieu J, Min SG, Fessi H. Effect of freeze-drying process conditions on the stability of nanoparticles. Dry Technol, 2004;22:335-46.
10. de Chasteigner S, Cavé G, Fessi H, Devissaguet J-P, Puisieux F. Freezedrying of itraconazole-loaded nanosphere suspensions: A feasibility study. Drug Dev Res, 1996;38:116-24.
11. Dulieu C, Bazile D. Influence of lipid nanocapsules composition on their aptness to freeze-drying. Pharm Res, 2005;22:285-92.
12. Fernandez-Urrusuno R, Romani D, Calvo P, Vila-Jato JL, Alonso MJ. Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. STP Pharm Sci, 1999;9:429-36.
13. Hennenfent KL, Govindan R. Novel formulations of taxanes: A review. Old wine in a new bottle Ann Oncol, 2006;17:735-49.
14. Hervella P, Lozano V, Garcia-Fuentes M, Alonso MJ. Nanomedicine: New challenges and opportunities in cancer therapy. J Biomed Nanotechnol, 2008;4:276-92.
15. Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. Physico-chemical stability of colloidal lipid particles. Biomaterials, 2003;24:4283-300.
16. Hwang HY, Kim S, Kwon IC, Kim YH. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release, 2008;128:23-31.
17. Janes KA, Alonso MJ. Depolymerized chitosan nanoparticles for protein delivery: Preparation and characterization. J Appl Polym Sci, 2003; 88:2769-76.
18. Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release, 2001;73:255-67.
19. Khalid MN, Simard P, Hoarau D, Dragomir A, Leroux JC. Long circulating poly(ethylene-glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm Res, 2007;23:752-8.
20. Lozano MV, Torrecilla D, Torres D, Vidal A, Dominguez F, Alonso MJ. Highly efficient system to deliver taxanes into tumor cells: Docetaxelloaded chitosan oligomer colloidal carriers. Biomacromolecules, 2008; 9:2186-93.
21. Mitra S, Gaur U, Ghosh PC, Maitra AN. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release, 2001;74:317-23.
22. Molina MC, Armstrong TK, Zhang Y, Patel MM, Lentz YK, Anchordoquy TJ. The stability of lyophilized lipid/DNA complexes during prolonged storage. J Pharm Sci, 2004;93:2259-73.
23. Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm, 2010;385:113-42.
24. Morille M, Montier T, Legras P, Carmoy N, Brodin P, Pitard B, Benoit JP, Passirani C. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials, 2010;31:321-9.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods, 1983;65:55-63.
26. Prego C, Brasa B, Fernandez-Megia E, Novoa-Carballal R, Torres D. 2006a. Long-term stability of chitosan and chitosan-PEG nanocapsule suspensions, Proceeding of 33rd Controlled Release Society, 22-26 July 2006, Vienna, Austria.
27. Prego C, Torres D, Alonso MJ. Chitosan nanocapsules as carriers for oral peptide delivery: Effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness. J Nanosci Nanotechnol, 2006b;6:2921-8.
28. Prego C, Torres D, Alonso MJ. Chitosan nanocapsules: A new carrier for nasal peptide delivery. J Drug Del Sci Tech, 2006c;16:331-7.
29. Saez A, Guzman M, Molpeceres J, Aberturas MR. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm, 2000;50:379-87.
30. Sameti M, Bohr G, Ravi Kumar MN, Kneuer C, Bakowsky U, Nacken M, Schmidt H, Lehr CM. Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery. Int J Pharm, 2003;266:51-60.
31. Santander-Ortega MJ, Lozano-López MV, Bastos-González D, Peula-García JM, Ortega-Vinuesa JL. Novel core-shell lipid-chitosan and lipid-poloxamer nanocapsules: Stability by hydration forces. Colloid Polym Sci, 2010;288:159-72.
32. Scheinberg DA, Villa CH, Escorcia FE, McDevitt MR. Conscripts of the infinite armada: Systemic cancer therapy using nanomaterials. Nat Rev Clin Oncol, 2010;7:266-76.
33. van Winden ECA. 2004. Freeze-drying of liposomes: A critical review of mechanisms involved in lyoprotection and solid-state stability. In: Costantino HR, ed. Lyophilization of biopharmaceuticals. Arlington, VA: AAPS Press, pp. 563-604.
34. Vinchon-Petit S, Jarnet D, Paillard A, Benoit JP, Garcion E, Menei P. In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: Distribution and radiosensitisation efficacy. J Neurooncol, 2010;97:195-205.
35. Zimmermann E, Muller RH, Mader K. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm, 2000;196: 211-13.